GlassScriptPhysician profile
Ibrahim M Ali
NPI 1821476060
$24,618.11
in general payments reported to CMS, 2019-2025
26 companies · $5,648 in 2025
The $5,648 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2022: $7,322 · 2023: $10K · 2024: $1,328 · 2025: $5,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,798 · Travel and Lodging: $4,232 · Consulting Fee: $3,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,798.01 |
| Travel and Lodging | $4,232.29 |
| Consulting Fee | $3,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,114.76 | 2022-2025 | Supera, Perclose Prostyle, Jeti |
| Medtronic, INC. | $4,535.63 | 2022-2025 | Symplicity G3, Hawkone, Corevalve Evolut R |
| Shockwave Medical, INC | $3,958.12 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $3,763.24 | 2022-2025 | (9520) Igt Devices Undivided, Turbo Elite, (6571) Eagle Eye |
| Zoll Circulation INC | $3,267.39 | 2024-2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Asahi Intecc USA, INC. | $621.89 | 2025 | Asahi Coronary Wires, Asahi Sion Blue |
| Bard Peripheral Vascular, INC. | $614.31 | 2022-2023 | Venovo, Crosser Iq, Lifestream |
| Abiomed | $548.33 | 2023-2024 | Impella |
| Boston Scientific Corporation | $416.90 | 2023-2025 | General - Balloon Catheters, Rotapro, Mdu5 Plus Sterile Bag |
| Cagent Vascular INC | $346.38 | 2023 | Serrantor |
| Amgen INC. | $339.00 | 2022-2025 | Repatha, Repatha |
| Cook Medical LLC | $227.51 | 2023 | Zilver Ptx |
| Novartis Pharmaceuticals Corporation | $220.21 | 2024-2025 | |
| Pfizer INC. | $141.81 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $126.12 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.91 | 2024-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $55.87 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Cardioform Septal Occluder |
| Cardiovascular Systems INC. | $46.54 | 2022 | |
| Penumbra, INC. | $40.27 | 2025 | Indigo System |
| Angiodynamics, INC. | $36.71 | 2025 | Alphavac |
| Cardiva Medical, INC. | $26.68 | 2022 | |
| Edwards Lifesciences Corporation | $24.90 | 2022 | |
| Bridgebio Pharma, INC. | $23.66 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.33 | 2023 | Lifevest |
| Heartflow, INC. | $20.69 | 2024 | |
| Chiesi USA, INC. | $16.95 | 2024 | Kengreal, Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.